# Functional and internalizing disorders co-aggregate with cardiometabolic and immune-related diseases within families: a population-based cohort study

**Authors:** Olivier D. Steen, Martje Bos, Sonja L. van Ockenburg, Yiling Zhou, Ilja M. Nolte, Harold Snieder, Kenneth Kendler, Judith G. M. Rosmalen, Hanna M. van Loo

PMC · DOI: 10.1186/s12916-025-04293-7 · BMC Medicine · 2025-08-11

## TL;DR

This study finds that functional and internalizing disorders, like chronic fatigue and depression, share family risk with immune and heart-related diseases, suggesting shared underlying causes.

## Contribution

The study reveals familial co-aggregation patterns between functional/internalizing disorders and cardiometabolic/immune diseases, suggesting shared risk factors.

## Key findings

- Functional and internalizing disorders co-aggregate with immune-related diseases (λR range 1.06–1.24).
- ME/CFS, FM, and MDD co-aggregate with most cardiometabolic diseases (λR range 1.00–1.23).
- MDD, fibromyalgia, and ME/CFS show similar familial correlation patterns with both disease groups (rf range 0.12–0.44).

## Abstract

Functional disorders share familial risk with internalizing disorders such as generalized anxiety disorder and depression, and are comorbid with cardiometabolic and immune-related diseases. We investigated whether functional and internalizing disorders co-aggregate with these diseases in families to gain insight into the aetiology of functional and internalizing disorders.

We included 166,774 subjects (aged 3–94), from the population-based Lifelines Cohort Study, a Dutch general population cohort. We defined cases for three functional disorders (myalgic encephalomyelitis/chronic fatigue syndrome; ME/CFS, fibromyalgia, and irritable bowel syndrome; IBS), two internalizing disorders (major depressive disorder; MDD and generalized anxiety disorder; GAD), cardiometabolic diseases (obesity, metabolic associated steatotic liver disease, type 2 diabetes, hypertension and cardiovascular disease) and immune-related diseases (composite measures of auto-immune disease and atopy). We used logistic regression to model the prevalence of these disorders in the general population and in participants with affected relatives. Using these prevalence estimates, we assessed familial co-aggregation with (1) recurrence risk ratios (λR), and (2) familial correlations (rf).

All functional and internalizing disorders co-aggregated with immune-related diseases (λR range 1.06–1.24). ME/CFS, FM, and MDD co-aggregated with most cardiometabolic diseases (λR range 1.00–1.23). MDD, fibromyalgia, and ME/CFS showed similar familial correlation patterns with both disease groups (rf range 0.12–0.44), while patterns of IBS and GAD were more variable.

Internalizing and functional disorders share familial risk with immune-related and cardiometabolic diseases. This suggests that risk factors relevant to immune-related and cardiometabolic diseases may also be relevant for FDs. Future studies should investigate such risk factors to identify novel treatment targets.

The online version contains supplementary material available at 10.1186/s12916-025-04293-7.

## Linked entities

- **Diseases:** fibromyalgia (MONDO:0005546), irritable bowel syndrome (MONDO:0005052), major depressive disorder (MONDO:0002009), generalized anxiety disorder (MONDO:0001942), obesity (MONDO:0011122), type 2 diabetes (MONDO:0005148), cardiovascular disease (MONDO:0004995), auto-immune disease (MONDO:0007179)

## Full-text entities

- **Diseases:** irritable bowel syndrome (MESH:D043183), myalgic encephalomyelitis/chronic fatigue syndrome (MESH:D015673), obesity (MESH:D009765), atopy (MESH:C564133), hypertension (MESH:D006973), IBS (MESH:D053560), generalized anxiety disorder (MESH:C000726808), MDD (MESH:D003865), type 2 diabetes (MESH:D003924), fibromyalgia (MESH:D005356), internalizing disorders (MESH:D000082122), steatotic liver disease (MESH:D008107), depression (MESH:D003866), cardiovascular disease (MESH:D002318), immune-related diseases (MESH:D007154), cardiometabolic and (MESH:D024821), auto-immune disease (MESH:C538437)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12337435/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12337435/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12337435/full.md

---
Source: https://tomesphere.com/paper/PMC12337435